Study
Comprehensive genetic analysis of Epstein-Barr virus-associated hematological malignancy
| Study ID | Alternative Stable ID | Type |
|---|---|---|
| EGAS00001003159 | Other |
Study Description
Comprehensive genetic analyses including whole-exome sequencing, targeted sequencing, and whole-genome sequencing of the human genome and the Epstein-Barr virus (EBV) genome were performed to reveal the molecular pathogenesis of EBV-associated hematological malignancy.
Study Datasets 4 datasets.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001004286 |
Comprehensive genetic analyses including whole-exome sequencing, targeted sequencing, and whole-genome sequencing of the human genome and the Epstein-Barr virus (EBV) genome were performed to reveal the molecular pathogenesis of EBV-associated hematological malignancy.
|
Illumina HiSeq 2500 | 453 |
| EGAD00001004297 |
Lymphoblastoid cell lines established using either wildtype or BALF5-deficient Epstein-Barr virus were analyzed by RNA sequencing.
|
Illumina HiSeq 2500 | 2 |
| EGAD00001004298 |
Capture-based whole-genome sequencing of Epstein-Barr virus (EBV) was performed in hematological malignancies such as EBV-positive diffuse large B-cell lymphoma, extranodal NK/T-cell lymphoma, and chronic active EBV infection.
|
Illumina HiSeq 2500 | 264 |
| EGAD00001004299 |
Comprehensive genetic analyses including whole-exome sequencing, targeted sequencing, and whole-genome sequencing were performed to reveal the molecular pathogenesis of chronic active Epstein-Barr virus infection.
|
Illumina HiSeq 2500 | 187 |
Who archives the data?
Publications
Citations
Retrieving...
Retrieving...
